Global Oncolytic Virus Therapy Market 2022 by Company, Regions, Type and Application, Forecast to 2028
Page: 104
Published Date: 04 Jan 2022
Category: Medical Care
PDF Download
Get FREE Sample
Customize Request
- Description
- Table of Contents
- Table of Figures
- Research Methodology
- Companies Mentioned
- Related Reports
- Product Tags
Description
The Oncolytic Virus Therapy market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our (Global Info Research) latest study, due to COVID-19 pandemic, the global Oncolytic Virus Therapy market size is estimated to be worth US$ 6 million in 2021 and is forecast to a readjusted size of USD 28 million by 2028 with a CAGR of 23.8% during review period. Melanoma accounting for % of the Oncolytic Virus Therapy global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While HSV-based Oncolytic Viruses segment is altered to a % CAGR between 2022 and 2028.
Global key companies of Oncolytic Virus Therapy include Amgen, Oncolytics Biotech, Viralytics, Transgene SA, and Oncolys BioPharma, etc. In terms of revenue, the global top four players hold a share over % in 2021.
Market segmentation
Oncolytic Virus Therapy market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
HSV-based Oncolytic Viruses
Adenoviruses-based Oncolytic Viruses
Vaccinia Virus-based Oncolytic Viruses
Vesicular Stomatitis Virus-based Oncolytic Viruses
Newcastle Disease Virus-based Oncolytic Viruses
Market segment by Application, can be divided into
Melanoma
Prostate Cancer
Breast Cancer
Ovarian Cancer
Others
Market segment by players, this report covers
Amgen
Oncolytics Biotech
Viralytics
Transgene SA
Oncolys BioPharma
Targovax
PsiOxus Therapeutics
SillaJen Biotherapeutics
Sorrento Therapeutics
Lokon Pharma
Genelux Corporation
Vyriad
TILT Biotherapeutics
Cold Genesys
Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
South America (Brazil, Argentina, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 12 chapters:
Chapter 1, to describe Oncolytic Virus Therapy product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top players of Oncolytic Virus Therapy, with revenue, gross margin and global market share of Oncolytic Virus Therapy from 2019 to 2022.
Chapter 3, the Oncolytic Virus Therapy competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with revenue and growth rate by Type, application, from 2017 to 2028.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2017 to 2022.and Oncolytic Virus Therapy market forecast, by regions, type and application, with revenue, from 2023 to 2028.
Chapter 11 and 12, to describe Oncolytic Virus Therapy research findings and conclusion, appendix and data source.
Table of Contents
1 Market Overview
1.1 Product Overview and Scope of Oncolytic Virus Therapy
1.2 Classification of Oncolytic Virus Therapy by Type
1.2.1 Overview: Global Oncolytic Virus Therapy Market Size by Type: 2017 Versus 2021 Versus 2028
1.2.2 Global Oncolytic Virus Therapy Revenue Market Share by Type in 2021
1.2.3 HSV-based Oncolytic Viruses
1.2.4 Adenoviruses-based Oncolytic Viruses
1.2.5 Vaccinia Virus-based Oncolytic Viruses
1.2.6 Vesicular Stomatitis Virus-based Oncolytic Viruses
1.2.7 Newcastle Disease Virus-based Oncolytic Viruses
1.3 Global Oncolytic Virus Therapy Market by Application
1.3.1 Overview: Global Oncolytic Virus Therapy Market Size by Application: 2017 Versus 2021 Versus 2028
1.3.2 Melanoma
1.3.3 Prostate Cancer
1.3.4 Breast Cancer
1.3.5 Ovarian Cancer
1.3.6 Others
1.4 Global Oncolytic Virus Therapy Market Size & Forecast
1.5 Global Oncolytic Virus Therapy Market Size and Forecast by Region
1.5.1 Global Oncolytic Virus Therapy Market Size by Region: 2017 VS 2021 VS 2028
1.5.2 Global Oncolytic Virus Therapy Market Size by Region, (2017-2022)
1.5.3 North America Oncolytic Virus Therapy Market Size and Prospect (2017-2028)
1.5.4 Europe Oncolytic Virus Therapy Market Size and Prospect (2017-2028)
1.5.5 Asia-Pacific Oncolytic Virus Therapy Market Size and Prospect (2017-2028)
1.5.6 South America Oncolytic Virus Therapy Market Size and Prospect (2017-2028)
1.5.7 Middle East and Africa Oncolytic Virus Therapy Market Size and Prospect (2017-2028)
1.6 Market Drivers, Restraints and Trends
1.6.1 Oncolytic Virus Therapy Market Drivers
1.6.2 Oncolytic Virus Therapy Market Restraints
1.6.3 Oncolytic Virus Therapy Trends Analysis
2 Company Profiles
2.1 Amgen
2.1.1 Amgen Details
2.1.2 Amgen Major Business
2.1.3 Amgen Oncolytic Virus Therapy Product and Solutions
2.1.4 Amgen Oncolytic Virus Therapy Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.1.5 Amgen Recent Developments and Future Plans
2.2 Oncolytics Biotech
2.2.1 Oncolytics Biotech Details
2.2.2 Oncolytics Biotech Major Business
2.2.3 Oncolytics Biotech Oncolytic Virus Therapy Product and Solutions
2.2.4 Oncolytics Biotech Oncolytic Virus Therapy Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.2.5 Oncolytics Biotech Recent Developments and Future Plans
2.3 Viralytics
2.3.1 Viralytics Details
2.3.2 Viralytics Major Business
2.3.3 Viralytics Oncolytic Virus Therapy Product and Solutions
2.3.4 Viralytics Oncolytic Virus Therapy Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.3.5 Viralytics Recent Developments and Future Plans
2.4 Transgene SA
2.4.1 Transgene SA Details
2.4.2 Transgene SA Major Business
2.4.3 Transgene SA Oncolytic Virus Therapy Product and Solutions
2.4.4 Transgene SA Oncolytic Virus Therapy Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.4.5 Transgene SA Recent Developments and Future Plans
2.5 Oncolys BioPharma
2.5.1 Oncolys BioPharma Details
2.5.2 Oncolys BioPharma Major Business
2.5.3 Oncolys BioPharma Oncolytic Virus Therapy Product and Solutions
2.5.4 Oncolys BioPharma Oncolytic Virus Therapy Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.5.5 Oncolys BioPharma Recent Developments and Future Plans
2.6 Targovax
2.6.1 Targovax Details
2.6.2 Targovax Major Business
2.6.3 Targovax Oncolytic Virus Therapy Product and Solutions
2.6.4 Targovax Oncolytic Virus Therapy Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.6.5 Targovax Recent Developments and Future Plans
2.7 PsiOxus Therapeutics
2.7.1 PsiOxus Therapeutics Details
2.7.2 PsiOxus Therapeutics Major Business
2.7.3 PsiOxus Therapeutics Oncolytic Virus Therapy Product and Solutions
2.7.4 PsiOxus Therapeutics Oncolytic Virus Therapy Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.7.5 PsiOxus Therapeutics Recent Developments and Future Plans
2.8 SillaJen Biotherapeutics
2.8.1 SillaJen Biotherapeutics Details
2.8.2 SillaJen Biotherapeutics Major Business
2.8.3 SillaJen Biotherapeutics Oncolytic Virus Therapy Product and Solutions
2.8.4 SillaJen Biotherapeutics Oncolytic Virus Therapy Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.8.5 SillaJen Biotherapeutics Recent Developments and Future Plans
2.9 Sorrento Therapeutics
2.9.1 Sorrento Therapeutics Details
2.9.2 Sorrento Therapeutics Major Business
2.9.3 Sorrento Therapeutics Oncolytic Virus Therapy Product and Solutions
2.9.4 Sorrento Therapeutics Oncolytic Virus Therapy Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.9.5 Sorrento Therapeutics Recent Developments and Future Plans
2.10 Lokon Pharma
2.10.1 Lokon Pharma Details
2.10.2 Lokon Pharma Major Business
2.10.3 Lokon Pharma Oncolytic Virus Therapy Product and Solutions
2.10.4 Lokon Pharma Oncolytic Virus Therapy Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.10.5 Lokon Pharma Recent Developments and Future Plans
2.11 Genelux Corporation
2.11.1 Genelux Corporation Details
2.11.2 Genelux Corporation Major Business
2.11.3 Genelux Corporation Oncolytic Virus Therapy Product and Solutions
2.11.4 Genelux Corporation Oncolytic Virus Therapy Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.11.5 Genelux Corporation Recent Developments and Future Plans
2.12 Vyriad
2.12.1 Vyriad Details
2.12.2 Vyriad Major Business
2.12.3 Vyriad Oncolytic Virus Therapy Product and Solutions
2.12.4 Vyriad Oncolytic Virus Therapy Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.12.5 Vyriad Recent Developments and Future Plans
2.13 TILT Biotherapeutics
2.13.1 TILT Biotherapeutics Details
2.13.2 TILT Biotherapeutics Major Business
2.13.3 TILT Biotherapeutics Oncolytic Virus Therapy Product and Solutions
2.13.4 TILT Biotherapeutics Oncolytic Virus Therapy Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.13.5 TILT Biotherapeutics Recent Developments and Future Plans
2.14 Cold Genesys
2.14.1 Cold Genesys Details
2.14.2 Cold Genesys Major Business
2.14.3 Cold Genesys Oncolytic Virus Therapy Product and Solutions
2.14.4 Cold Genesys Oncolytic Virus Therapy Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.14.5 Cold Genesys Recent Developments and Future Plans
3 Market Competition, by Players
3.1 Global Oncolytic Virus Therapy Revenue and Share by Players (2019, 2020, 2021, and 2022)
3.2 Market Concentration Rate
3.2.1 Top 3 Oncolytic Virus Therapy Players Market Share in 2021
3.2.2 Top 10 Oncolytic Virus Therapy Players Market Share in 2021
3.2.3 Market Competition Trend
3.3 Oncolytic Virus Therapy Players Head Office, Products and Services Provided
3.4 Oncolytic Virus Therapy Mergers & Acquisitions
3.5 Oncolytic Virus Therapy New Entrants and Expansion Plans
4 Market Size Segment by Type
4.1 Global Oncolytic Virus Therapy Revenue and Market Share by Type (2017-2022)
4.2 Global Oncolytic Virus Therapy Market Forecast by Type (2023-2028)
5 Market Size Segment by Application
5.1 Global Oncolytic Virus Therapy Revenue Market Share by Application (2017-2022)
5.2 Global Oncolytic Virus Therapy Market Forecast by Application (2023-2028)
6 North America by Country, by Type, and by Application
6.1 North America Oncolytic Virus Therapy Revenue by Type (2017-2028)
6.2 North America Oncolytic Virus Therapy Revenue by Application (2017-2028)
6.3 North America Oncolytic Virus Therapy Market Size by Country
6.3.1 North America Oncolytic Virus Therapy Revenue by Country (2017-2028)
6.3.2 United States Oncolytic Virus Therapy Market Size and Forecast (2017-2028)
6.3.3 Canada Oncolytic Virus Therapy Market Size and Forecast (2017-2028)
6.3.4 Mexico Oncolytic Virus Therapy Market Size and Forecast (2017-2028)
7 Europe by Country, by Type, and by Application
7.1 Europe Oncolytic Virus Therapy Revenue by Type (2017-2028)
7.2 Europe Oncolytic Virus Therapy Revenue by Application (2017-2028)
7.3 Europe Oncolytic Virus Therapy Market Size by Country
7.3.1 Europe Oncolytic Virus Therapy Revenue by Country (2017-2028)
7.3.2 Germany Oncolytic Virus Therapy Market Size and Forecast (2017-2028)
7.3.3 France Oncolytic Virus Therapy Market Size and Forecast (2017-2028)
7.3.4 United Kingdom Oncolytic Virus Therapy Market Size and Forecast (2017-2028)
7.3.5 Russia Oncolytic Virus Therapy Market Size and Forecast (2017-2028)
7.3.6 Italy Oncolytic Virus Therapy Market Size and Forecast (2017-2028)
8 Asia-Pacific by Region, by Type, and by Application
8.1 Asia-Pacific Oncolytic Virus Therapy Revenue by Type (2017-2028)
8.2 Asia-Pacific Oncolytic Virus Therapy Revenue by Application (2017-2028)
8.3 Asia-Pacific Oncolytic Virus Therapy Market Size by Region
8.3.1 Asia-Pacific Oncolytic Virus Therapy Revenue by Region (2017-2028)
8.3.2 China Oncolytic Virus Therapy Market Size and Forecast (2017-2028)
8.3.3 Japan Oncolytic Virus Therapy Market Size and Forecast (2017-2028)
8.3.4 South Korea Oncolytic Virus Therapy Market Size and Forecast (2017-2028)
8.3.5 India Oncolytic Virus Therapy Market Size and Forecast (2017-2028)
8.3.6 Southeast Asia Oncolytic Virus Therapy Market Size and Forecast (2017-2028)
8.3.7 Australia Oncolytic Virus Therapy Market Size and Forecast (2017-2028)
9 South America by Country, by Type, and by Application
9.1 South America Oncolytic Virus Therapy Revenue by Type (2017-2028)
9.2 South America Oncolytic Virus Therapy Revenue by Application (2017-2028)
9.3 South America Oncolytic Virus Therapy Market Size by Country
9.3.1 South America Oncolytic Virus Therapy Revenue by Country (2017-2028)
9.3.2 Brazil Oncolytic Virus Therapy Market Size and Forecast (2017-2028)
9.3.3 Argentina Oncolytic Virus Therapy Market Size and Forecast (2017-2028)
10 Middle East & Africa by Country, by Type, and by Application
10.1 Middle East & Africa Oncolytic Virus Therapy Revenue by Type (2017-2028)
10.2 Middle East & Africa Oncolytic Virus Therapy Revenue by Application (2017-2028)
10.3 Middle East & Africa Oncolytic Virus Therapy Market Size by Country
10.3.1 Middle East & Africa Oncolytic Virus Therapy Revenue by Country (2017-2028)
10.3.2 Turkey Oncolytic Virus Therapy Market Size and Forecast (2017-2028)
10.3.3 Saudi Arabia Oncolytic Virus Therapy Market Size and Forecast (2017-2028)
10.3.4 UAE Oncolytic Virus Therapy Market Size and Forecast (2017-2028)
11 Research Findings and Conclusion
12 Appendix
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer
Table of Figures
List of Tables
Table 1. Global Oncolytic Virus Therapy Revenue by Type, (USD Million), 2017 VS 2021 VS 2028
Table 2. Global Oncolytic Virus Therapy Revenue by Application, (USD Million), 2017 VS 2021 VS 2028
Table 3. Global Market Oncolytic Virus Therapy Revenue (Million USD) Comparison by Region (2017 VS 2021 VS 2028)
Table 4. Global Oncolytic Virus Therapy Revenue (USD Million) by Region (2017-2022)
Table 5. Global Oncolytic Virus Therapy Revenue Market Share by Region (2023-2028)
Table 6. Amgen Corporate Information, Head Office, and Major Competitors
Table 7. Amgen Major Business
Table 8. Amgen Oncolytic Virus Therapy Product and Solutions
Table 9. Amgen Oncolytic Virus Therapy Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 10. Oncolytics Biotech Corporate Information, Head Office, and Major Competitors
Table 11. Oncolytics Biotech Major Business
Table 12. Oncolytics Biotech Oncolytic Virus Therapy Product and Solutions
Table 13. Oncolytics Biotech Oncolytic Virus Therapy Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 14. Viralytics Corporate Information, Head Office, and Major Competitors
Table 15. Viralytics Major Business
Table 16. Viralytics Oncolytic Virus Therapy Product and Solutions
Table 17. Viralytics Oncolytic Virus Therapy Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 18. Transgene SA Corporate Information, Head Office, and Major Competitors
Table 19. Transgene SA Major Business
Table 20. Transgene SA Oncolytic Virus Therapy Product and Solutions
Table 21. Transgene SA Oncolytic Virus Therapy Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 22. Oncolys BioPharma Corporate Information, Head Office, and Major Competitors
Table 23. Oncolys BioPharma Major Business
Table 24. Oncolys BioPharma Oncolytic Virus Therapy Product and Solutions
Table 25. Oncolys BioPharma Oncolytic Virus Therapy Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 26. Targovax Corporate Information, Head Office, and Major Competitors
Table 27. Targovax Major Business
Table 28. Targovax Oncolytic Virus Therapy Product and Solutions
Table 29. Targovax Oncolytic Virus Therapy Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 30. PsiOxus Therapeutics Corporate Information, Head Office, and Major Competitors
Table 31. PsiOxus Therapeutics Major Business
Table 32. PsiOxus Therapeutics Oncolytic Virus Therapy Product and Solutions
Table 33. PsiOxus Therapeutics Oncolytic Virus Therapy Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 34. SillaJen Biotherapeutics Corporate Information, Head Office, and Major Competitors
Table 35. SillaJen Biotherapeutics Major Business
Table 36. SillaJen Biotherapeutics Oncolytic Virus Therapy Product and Solutions
Table 37. SillaJen Biotherapeutics Oncolytic Virus Therapy Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 38. Sorrento Therapeutics Corporate Information, Head Office, and Major Competitors
Table 39. Sorrento Therapeutics Major Business
Table 40. Sorrento Therapeutics Oncolytic Virus Therapy Product and Solutions
Table 41. Sorrento Therapeutics Oncolytic Virus Therapy Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 42. Lokon Pharma Corporate Information, Head Office, and Major Competitors
Table 43. Lokon Pharma Major Business
Table 44. Lokon Pharma Oncolytic Virus Therapy Product and Solutions
Table 45. Lokon Pharma Oncolytic Virus Therapy Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 46. Genelux Corporation Corporate Information, Head Office, and Major Competitors
Table 47. Genelux Corporation Major Business
Table 48. Genelux Corporation Oncolytic Virus Therapy Product and Solutions
Table 49. Genelux Corporation Oncolytic Virus Therapy Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 50. Vyriad Corporate Information, Head Office, and Major Competitors
Table 51. Vyriad Major Business
Table 52. Vyriad Oncolytic Virus Therapy Product and Solutions
Table 53. Vyriad Oncolytic Virus Therapy Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 54. TILT Biotherapeutics Corporate Information, Head Office, and Major Competitors
Table 55. TILT Biotherapeutics Major Business
Table 56. TILT Biotherapeutics Oncolytic Virus Therapy Product and Solutions
Table 57. TILT Biotherapeutics Oncolytic Virus Therapy Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 58. Cold Genesys Corporate Information, Head Office, and Major Competitors
Table 59. Cold Genesys Major Business
Table 60. Cold Genesys Oncolytic Virus Therapy Product and Solutions
Table 61. Cold Genesys Oncolytic Virus Therapy Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 62. Global Oncolytic Virus Therapy Revenue (USD Million) by Players (2019, 2020, 2021, and 2022)
Table 63. Global Oncolytic Virus Therapy Revenue Share by Players (2019, 2020, 2021, and 2022)
Table 64. Breakdown of Oncolytic Virus Therapy by Company Type (Tier 1, Tier 2 and Tier 3)
Table 65. Oncolytic Virus Therapy Players Head Office, Products and Services Provided
Table 66. Oncolytic Virus Therapy Mergers & Acquisitions in the Past Five Years
Table 67. Oncolytic Virus Therapy New Entrants and Expansion Plans
Table 68. Global Oncolytic Virus Therapy Revenue (USD Million) by Type (2017-2022)
Table 69. Global Oncolytic Virus Therapy Revenue Share by Type (2017-2022)
Table 70. Global Oncolytic Virus Therapy Revenue Forecast by Type (2023-2028)
Table 71. Global Oncolytic Virus Therapy Revenue by Application (2017-2022)
Table 72. Global Oncolytic Virus Therapy Revenue Forecast by Application (2023-2028)
Table 73. North America Oncolytic Virus Therapy Revenue by Type (2017-2022) & (USD Million)
Table 74. North America Oncolytic Virus Therapy Revenue by Type (2023-2028) & (USD Million)
Table 75. North America Oncolytic Virus Therapy Revenue by Application (2017-2022) & (USD Million)
Table 76. North America Oncolytic Virus Therapy Revenue by Application (2023-2028) & (USD Million)
Table 77. North America Oncolytic Virus Therapy Revenue by Country (2017-2022) & (USD Million)
Table 78. North America Oncolytic Virus Therapy Revenue by Country (2023-2028) & (USD Million)
Table 79. Europe Oncolytic Virus Therapy Revenue by Type (2017-2022) & (USD Million)
Table 80. Europe Oncolytic Virus Therapy Revenue by Type (2023-2028) & (USD Million)
Table 81. Europe Oncolytic Virus Therapy Revenue by Application (2017-2022) & (USD Million)
Table 82. Europe Oncolytic Virus Therapy Revenue by Application (2023-2028) & (USD Million)
Table 83. Europe Oncolytic Virus Therapy Revenue by Country (2017-2022) & (USD Million)
Table 84. Europe Oncolytic Virus Therapy Revenue by Country (2023-2028) & (USD Million)
Table 85. Asia-Pacific Oncolytic Virus Therapy Revenue by Type (2017-2022) & (USD Million)
Table 86. Asia-Pacific Oncolytic Virus Therapy Revenue by Type (2023-2028) & (USD Million)
Table 87. Asia-Pacific Oncolytic Virus Therapy Revenue by Application (2017-2022) & (USD Million)
Table 88. Asia-Pacific Oncolytic Virus Therapy Revenue by Application (2023-2028) & (USD Million)
Table 89. Asia-Pacific Oncolytic Virus Therapy Revenue by Region (2017-2022) & (USD Million)
Table 90. Asia-Pacific Oncolytic Virus Therapy Revenue by Region (2023-2028) & (USD Million)
Table 91. South America Oncolytic Virus Therapy Revenue by Type (2017-2022) & (USD Million)
Table 92. South America Oncolytic Virus Therapy Revenue by Type (2023-2028) & (USD Million)
Table 93. South America Oncolytic Virus Therapy Revenue by Application (2017-2022) & (USD Million)
Table 94. South America Oncolytic Virus Therapy Revenue by Application (2023-2028) & (USD Million)
Table 95. South America Oncolytic Virus Therapy Revenue by Country (2017-2022) & (USD Million)
Table 96. South America Oncolytic Virus Therapy Revenue by Country (2023-2028) & (USD Million)
Table 97. Middle East & Africa Oncolytic Virus Therapy Revenue by Type (2017-2022) & (USD Million)
Table 98. Middle East & Africa Oncolytic Virus Therapy Revenue by Type (2023-2028) & (USD Million)
Table 99. Middle East & Africa Oncolytic Virus Therapy Revenue by Application (2017-2022) & (USD Million)
Table 100. Middle East & Africa Oncolytic Virus Therapy Revenue by Application (2023-2028) & (USD Million)
Table 101. Middle East & Africa Oncolytic Virus Therapy Revenue by Country (2017-2022) & (USD Million)
Table 102. Middle East & Africa Oncolytic Virus Therapy Revenue by Country (2023-2028) & (USD Million)
List of Figures
Figure 1. Oncolytic Virus Therapy Picture
Figure 2. Global Oncolytic Virus Therapy Revenue Market Share by Type in 2021
Figure 3. HSV-based Oncolytic Viruses
Figure 4. Adenoviruses-based Oncolytic Viruses
Figure 5. Vaccinia Virus-based Oncolytic Viruses
Figure 6. Vesicular Stomatitis Virus-based Oncolytic Viruses
Figure 7. Newcastle Disease Virus-based Oncolytic Viruses
Figure 8. Oncolytic Virus Therapy Revenue Market Share by Application in 2021
Figure 9. Melanoma Picture
Figure 10. Prostate Cancer Picture
Figure 11. Breast Cancer Picture
Figure 12. Ovarian Cancer Picture
Figure 13. Others Picture
Figure 14. Global Oncolytic Virus Therapy Market Size, (USD Million): 2017 VS 2021 VS 2028
Figure 15. Global Oncolytic Virus Therapy Revenue and Forecast (2017-2028) & (USD Million)
Figure 16. Global Oncolytic Virus Therapy Revenue Market Share by Region (2017-2028)
Figure 17. Global Oncolytic Virus Therapy Revenue Market Share by Region in 2021
Figure 18. North America Oncolytic Virus Therapy Revenue (USD Million) and Growth Rate (2017-2028)
Figure 19. Europe Oncolytic Virus Therapy Revenue (USD Million) and Growth Rate (2017-2028)
Figure 20. Asia-Pacific Oncolytic Virus Therapy Revenue (USD Million) and Growth Rate (2017-2028)
Figure 21. South America Oncolytic Virus Therapy Revenue (USD Million) and Growth Rate (2017-2028)
Figure 22. Middle East and Africa Oncolytic Virus Therapy Revenue (USD Million) and Growth Rate (2017-2028)
Figure 23. Oncolytic Virus Therapy Market Drivers
Figure 24. Oncolytic Virus Therapy Market Restraints
Figure 25. Oncolytic Virus Therapy Market Trends
Figure 26. Amgen Recent Developments and Future Plans
Figure 27. Oncolytics Biotech Recent Developments and Future Plans
Figure 28. Viralytics Recent Developments and Future Plans
Figure 29. Transgene SA Recent Developments and Future Plans
Figure 30. Oncolys BioPharma Recent Developments and Future Plans
Figure 31. Targovax Recent Developments and Future Plans
Figure 32. PsiOxus Therapeutics Recent Developments and Future Plans
Figure 33. SillaJen Biotherapeutics Recent Developments and Future Plans
Figure 34. Sorrento Therapeutics Recent Developments and Future Plans
Figure 35. Lokon Pharma Recent Developments and Future Plans
Figure 36. Genelux Corporation Recent Developments and Future Plans
Figure 37. Vyriad Recent Developments and Future Plans
Figure 38. TILT Biotherapeutics Recent Developments and Future Plans
Figure 39. Cold Genesys Recent Developments and Future Plans
Figure 40. Global Oncolytic Virus Therapy Revenue Share by Players in 2021
Figure 41. Oncolytic Virus Therapy Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2021
Figure 42. Global Top 3 Players Oncolytic Virus Therapy Revenue Market Share in 2021
Figure 43. Global Top 10 Players Oncolytic Virus Therapy Revenue Market Share in 2021
Figure 44. Key Players Market Share Trend (Top 3 Market Share: 2020 VS 2021 VS 2022)
Figure 45. Global Oncolytic Virus Therapy Revenue Share by Type in 2021
Figure 46. Global Oncolytic Virus Therapy Market Share Forecast by Type (2023-2028)
Figure 47. Global Oncolytic Virus Therapy Revenue Share by Application in 2021
Figure 48. Global Oncolytic Virus Therapy Market Share Forecast by Application (2023-2028)
Figure 49. North America Oncolytic Virus Therapy Sales Market Share by Type (2017-2028)
Figure 50. North America Oncolytic Virus Therapy Sales Market Share by Application (2017-2028)
Figure 51. North America Oncolytic Virus Therapy Revenue Market Share by Country (2017-2028)
Figure 52. United States Oncolytic Virus Therapy Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 53. Canada Oncolytic Virus Therapy Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 54. Mexico Oncolytic Virus Therapy Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 55. Europe Oncolytic Virus Therapy Sales Market Share by Type (2017-2028)
Figure 56. Europe Oncolytic Virus Therapy Sales Market Share by Application (2017-2028)
Figure 57. Europe Oncolytic Virus Therapy Revenue Market Share by Country (2017-2028)
Figure 58. Germany Oncolytic Virus Therapy Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 59. France Oncolytic Virus Therapy Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 60. United Kingdom Oncolytic Virus Therapy Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 61. Russia Oncolytic Virus Therapy Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 62. Italy Oncolytic Virus Therapy Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 63. Asia-Pacific Oncolytic Virus Therapy Sales Market Share by Type (2017-2028)
Figure 64. Asia-Pacific Oncolytic Virus Therapy Sales Market Share by Application (2017-2028)
Figure 65. Asia-Pacific Oncolytic Virus Therapy Revenue Market Share by Region (2017-2028)
Figure 66. China Oncolytic Virus Therapy Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 67. Japan Oncolytic Virus Therapy Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 68. South Korea Oncolytic Virus Therapy Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 69. India Oncolytic Virus Therapy Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 70. Southeast Asia Oncolytic Virus Therapy Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 71. Australia Oncolytic Virus Therapy Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 72. South America Oncolytic Virus Therapy Sales Market Share by Type (2017-2028)
Figure 73. South America Oncolytic Virus Therapy Sales Market Share by Application (2017-2028)
Figure 74. South America Oncolytic Virus Therapy Revenue Market Share by Country (2017-2028)
Figure 75. Brazil Oncolytic Virus Therapy Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 76. Argentina Oncolytic Virus Therapy Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 77. Middle East and Africa Oncolytic Virus Therapy Sales Market Share by Type (2017-2028)
Figure 78. Middle East and Africa Oncolytic Virus Therapy Sales Market Share by Application (2017-2028)
Figure 79. Middle East and Africa Oncolytic Virus Therapy Revenue Market Share by Country (2017-2028)
Figure 80. Turkey Oncolytic Virus Therapy Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 81. Saudi Arabia Oncolytic Virus Therapy Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 82. UAE Oncolytic Virus Therapy Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 83. Methodology
Figure 84. Research Process and Data Source
Research Methodology
Client Requirements
Review and analyze client requirements
Discussion of all the project requirements and queries
Flexibility Check
Project Feasibility Analysis
Finalizing tentative research programme
Structuring project proposal with scope, timeline, and costs
Analyzing Market Dynamics
Determination of key drivers, restraints, challenge, and opportunity
Identifies market needs and trends
Market Size Estimation & Forecast
Estimation of historical data based on secondary and primary data
Anticipating market recast by assigning weightage to market forces (drivers, restraints, opportunities)
Freezing historical and forecast market size estimations based on evolution, trends, outlook, and strategies
Consideration of geography, region-specific product/service demand for region segments
Consideration of product utilization rates, product demand outlook for segments by application or end-user.
Data Source
Secondary Source
Data collections from annual reports, presentations,associations, journals, analyst reports,
paid database, press releases, blogs, newsletters,and GIR repositories.
Primary Source
Research discussion with manufacturers, distributors, suppliers, end user, industry experts
to verify insights.
Validation
and
triangulation of
secondary and primary source.
Collection of data
Cumulating and collating the essential qualitative and quantitative data
Generation of report in client requested format by research analysts
Reviews by expert analysts
Final quality check
Clarifying queries
Receiving feedback
Ensuring satisfaction
01 Identification of data
This step involves identification of several primary and secondary data research sources, including Global Info Research's internal data sources. The primary sources consist of in-depth discussions and interviews with policy makers, industry experts, and data evaluators, whereas secondary sources include a thorough study of market journals, press releases, annual reports, and government and non-government agencies websites.
02 Evaluation of Market Dynamic
This phase includes a detailed evaluation of several factors that are likely to affect the market dynamics. It involves a comprehensive assessment of major market pain points, drivers, and trends. It also comprises a detailed study of research plans and methodology.
03 Collection of Data
This process consists of gathering data, accessing proprietary databases, and reaching out to key industry participants that operate in the market across the value chain. It also involves studying several patterns in the historical data and comparing it with the current scenario.
04 Collaboration of Data
This stage involves the validation of data and arrival at actual statistics, and evolution of the market over the years. It entails the study and analyzes various segments and verticals of the market. An impact analysis is also performed to observe which factors will affect the market in the next few years.
05 Verification and Analysis
This is the final stage, which involves both quantity and quality checks. Although the process of data verification is an integral part of the research process, all data points and statistics and figures are re-checked to uphold their authenticity and validity.
Companies Mentioned
Amgen Oncolytics Biotech Viralytics Transgene SA Oncolys BioPharma Targovax PsiOxus Therapeutics SillaJen Biotherapeutics Sorrento Therapeutics Lokon Pharma Genelux Corporation Vyriad TILT Biotherapeutics Cold Genesys
Related Reports
Purchase Options
Add To Cart
Buy Now
Popular Product Keywords
- We Provide Professional, Accurate Market Analysis to Help You Stay Ahead of Your Competition.Speak to our analyst >>
Our Clients
What We Can Provide?
With better results and higher quality products,Our professional reports can achieve four things:
-
Insight into the industry market information
-
Analyze market development needs
-
Prospects for future development
-
Develop industry investment strategy
-
- Digging deeper into global industry information and providing market strategies.Contact Us >>